Geron Corporation operates as a biopharmaceutical company in the United States. It develops and commercializes three groups of products: therapeutic products for oncology that target telomerase; pharmaceuticals that activate telomerase in tissues impacted by senescence, injury or degenerative disease; and cell-based therapies derived from its human embryonic stem cell platform for applications in various diseases. The company develops anti-cancer therapies based on telomerase inhibitors, telomerase therapeutic vaccines, as well as through its licensee, telomerase-based oncolytic viruses. It also develops drugs that activate telomerase for cell repair/function in senescent tissues...
Stock price of Geron Corporation (NASDAQ:GERN) has been quite unstable during the past days. After a week full of losses, on Friday the stock soared 2.76% and its traded volume jumped over 2 million shares. Though, the reason for the massive trade is yet unknown.read more
Geron Corporation (NASDAQ:GERN) flew up by 17.29% on Friday. The stock reached the price of $5.63 per share, and its traded volume rose up to over 5 million shares just for a day.read more
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
Stock price of Geron Corporation (NASDAQ:GERN) has been quite unstable during the past days. After a week full of losses, on Friday the stock soared 2.76% and its traded volume jumped over 2 million shares. Though, the reason for the massive trade is yet unknown.read more
Geron Corporation (NASDAQ:GERN) flew up by 17.29% on Friday. The stock reached the price of $5.63 per share, and its traded volume rose up to over 5 million shares just for a day.read more
